Transjugular intrahepatic portosystemic shunt

Digestive Diseases

Volumn 23, Issue 1, 2005, Pages 56-64

  Ochs, Andreas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Ascites; Budd Chiari syndrome; Cirrhosis; Endoscopic band ligation; Hepatic encephalopathy; Hepatic hydrothorax; Hepatorenal syndrome; Portal hypertension; TIPS; Variceal bleeding

Indexed keywords

POLITEF;

ANTICOAGULATION; ARTERY INJURY; ASCITES; BILE DUCT INJURY; BLEEDING; BLEEDING DISORDER; BUDD CHIARI SYNDROME; CLINICAL FEATURE; COMPETENCE; ECHOGRAPHY; ECTOPIC TISSUE; ENDOSCOPIC THERAPY; FISTULA; FOLLOW UP; GALLBLADDER PERFORATION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEMATOMA; HEMOLYSIS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYDROTHORAX; INTERMETHOD COMPARISON; KIDNEY DISEASE; LACERATION; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; LIVER TRANSPLANTATION; LONG TERM CARE; MEDICAL ASSESSMENT; MORTALITY; ORGAN INJURY; PARACENTESIS; PERITONEUM VEIN SHUNT; PNEUMOTHORAX; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SHUNTING; SKILL; STENOSIS; SURVIVAL RATE; TECHNIQUE; TREATMENT INDICATION; VARICOSIS; VASCULAR PATENCY;

ASCITES; HEMORRHAGE; HEPATIC VEIN THROMBOSIS; HUMANS; HYPERTENSION, PORTAL; LIVER; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RANDOMIZED CONTROLLED TRIALS; REGIONAL BLOOD FLOW; SURVIVAL ANALYSIS; VARICOSE VEINS;

EID: 20444459055     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084726     Document Type: Review

References (124)

1. Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO: Expandable intrahepatic portacaval shunt stents: Early experience in the dog. Am J Roentgenol 1985;145:821-825.
2. Rösch J, Hanafee W, Snow H, Barenfus M, Gray R: Transjugular intrahepatic portocaval shunt. Am J Surg 1971;121:588-592.
3. Colapinto RF, Stronell RD, Gildiner M, et al: Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: Preliminary clinical experience. AJR Am J Roentgenol 1983;140:709-714.
4. Gutierrez OH, Burgener FA: Production of nonsurgical portosystemic venous shunts in dogs by transjugular approach. Radiology 1979;130:507-509.
5. Rössle M, Richter GM, Nöldge G, et al: Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique - a case report. Hepatology 1988;8:1348A.
6. Gschwantler M, Gebauer A, Rohrmoser M, et al: Clinical outcome two years after implantation of a transjugular intrahepatic portosystemic shunt for recurrent variceal bleeding (see comments). Eur J Gastroenterol Hepatol 1997; 9:15-20.
7. Rössle M, Siegerstetter V, Huber M, Ochs A: The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art. Liver 1998;18:73-89.
8. Krajina A, Lojik M: TIPS Technique; in Hulek P, Krajina A (eds): Current Practice of TIPS. Hradec Kralove, Olga Stambergova, 2001, pp 56-119.
9. Haskal ZJ, Martin L, Cardella JF, et al: Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003;14:S265-S270.
10. Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K: How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001;96: 3379-3383.
11. Kleber G, Steudel N, Behrmann C, et al: Hepatic arterial flow volume and reserve in patients with cirrhosis: Use of intra-arterial Doppler and adenosine infusion. Gastroenterology 1999;116:906-914.
12. Gülberg V, Haag K, Rössle M, Gerbes AL: Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002;35:630-634.
13. Walser E, Ozkan OS, Raza S, Soloway R, Gajula L: Hepatic perfusion as a predictor of mortality after transjugular intrahepatic portosystemic shunt creation in patients with refractory ascites. J Vasc Interv Radiol 2003; 14:1251-1257.
14. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rössle M: Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743-748.
15. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H: Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: Preliminary report of a prospective study. Hepatology 1994;19:129-132.
16. Stanley AJ, Redhead DN, Bouchier IA, Hayes PC: Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis. Am J Gastroenterol 1998;93:2463-2468.
17. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC: Reduction in renal blood flow following acute increase in the portal pressure: Evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-670.
18. Wong F, Sniderman K, Liu P, Blendis LM: The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899-907.
19. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis LM: Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122:816-822.
20. Ochs A, Rössle M, Haag K, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197.
21. Tripathi D, Helmy A, Macbeth K, et al: Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol 2004;16:9-18.
22. Haag K, Ochs A, Deibert P, et al: Hemodynamics, liver function and clinical follow-up after TIPS (German). Radiologe 1994;34:183-186.
23. 3 Nagele T, Seeger U, Pereira P, et al: MR proton spectroscopy to monitor the concentration changes in cerebral metabolites following a TIPS placement. Röfo Fortschr Geb Rontgen-str Neuen Bildgeb Verfahr 1999;170:298-303.
24. Hauenstein KH, Haag K, Ochs A, Langer M, Rössle M: The reducing stent: Treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 1995;194:175-179.
25. Rose SE, Katz MD: Intentional occlusion of a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 1995;18:109-111.
26. Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum RA, Redd DC: Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195:485-488.
27. Haag K, Ochs A, Hauenstein KH, Siegerstetter V, Deibert P, Rössle M: Management of TIPS-induced refractory hepatic encephalopathy. Hepatology 1994;20:111A.
28. Mamiya Y, Kanazawa H, Kimura Y, et al: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Hepatol Res 2004;30:162-168.
29. Chalasani N, Clark WS, Martin LG, et al: Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138-144.
30. Brown DB, Fundakowski CE, Lisker-Melman M, et al: Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Intervent Radiol 2004;15:1209-1218.
31. Schepke M, Roth F, Fimmers R, et al: Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98: 1167-1174.
32. Schepke M, Roth F, Koch L, et al: Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding. Digestion 2003;67: 146-153.
33. Alessandria C, Gaia S, Marzano A, Venon WD, Fadda M, Rizzetto M: Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment. Eur J Gastroenterol Hepatol 2004;16:607-612.
34. Benito A, Bilbao J, Hernandez T, et al: Doppler ultrasound for TIPS: Does it work? Abdom Imaging 2004;29:45-52.
35. Middleton WD, Teefey SA, Darcy MD: Doppler evaluation of transjugular intrahepatic portosystemic shunts. Ultrasound Q 2003; 19:56-70.
36. Wachsberg RH: Doppler ultrasound evaluation of transjugular intrahepatic portosystemic shunt function: Pitfalls and artifacts. Ultrasound Q 2003;19:139-148.
37. Murphy TP, Beecham RP, Kim HM, Webb MS, Scola F: Long-term follow-up after TIPS: Use of Doppler velocity criteria for detecting elevation of the portosystemic gradient. J Vasc Interv Radiol 1998;9:275-281.
38. Zizka J, Elias P, Krajina A, et al: Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: A 5-year experience in 216 patients. AJR Am J Roentgenol 2000;175:141-148.
39. Haag K: Color Doppler Imaging of Abdominal Vessels; in Lanzer P, Yoganathan AP (eds): Vascular Imaging by Color Doppler and Magnetic Resonance. Berlin, Springer, 1991, pp 241-265.
40. Siegerstetter V, Huber M, Ochs A, Blum HE, Rössle M: Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: A randomized study comparing trapidil plus ticlopidine with heparin treatment. Hepatology 1999;29:33-38.
41. Angermayr B, Cejna M, Koenig F, et al: Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003;38:1043-1050.
42. Hausegger KA, Portugaller H, Macri NP, et al: Covered stents in transjugular portosystemic shunt: healing response to non-porous ePTFE covered stent grafts with and without intraluminal irradiation. Eur Radiol 2003;13:1549-1558.
43. Cejna M, Peck-Radosavljevic M, Thurnher S, et al: ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 2002;25:365-372.
44. DiSalle RS, Dolmatch BL: Treatment of TIPS stenosis with ePTFE graft-covered stents. Cardiovasc Intervent Radiol 1998;21:172-175.
45. Charon JP, Alaeddin FH, Pimpalwar SA, et al: Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004;15:1219-1230.
46. Imperiale TF, Teran JC, McCullough AJ: A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 1995; 109:1289-1294.
47. Ioannou G, Doust J, Rockey DC: Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2001;CD002147.
48. Sharara AI, Rockey DC: Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345: 669-681.
49. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: A Cochrane meta-analysis. Gastroenterology 2003; 124:1277-1291.
50. Avgerinos A, Armonis A, Manolakopoulos S, et al: Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study. J Hepatol 1997;26:1034-1041.
51. Gross M, Schiemann U, Muhlhofer A, Zoller WG: Meta-analysis: Efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001;33:737-746.
52. Burroughs AK, McCormick PA: Prevention of variceal rebleeding. Gastroenterol Clin North Am 1992;21:119-147.
53. Technology Assessment Status Evaluation - Update: Endoscopic band ligation. November, 1996. ASGE. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1998; 47:573-575.
54. Laine L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995;123:280-287.
55. Haag K, Rössle M, Hauenstein KH, et al: Der transjuguläre intrahepatische portosystemische Stent-Shunt (TIPS) in der Notfallbehandlung der portalen Hypertension. Intensivmedizin 1993;30:479-483.
56. Le Moine O, Deviere J, Ghysels M, et al: Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol 1994;207(suppl):23-28.
57. McCormick PA, Dick R, Panagou EB, et al: Emergency transjugular intrahepatic portosystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81:1324-1327.
58. Jalan R, John TG, Redhead DN, et al: A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage (see comments). Am J Gastroenterol 1995;90:1932-1937.
59. Sanyal AJ, Freedman AM, Luketic VA, et al: Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996;111:138-146.
60. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK: 'Salvage' transjugular intrahepatic portosystemic shunts: Gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981-987.
61. Banares R, Casado M, Rodriguez-Laiz JM, et al: Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998;93:75-79.
62. Patch D, Nikolopoulou V, McCormick A, et al: Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998:28:454-460.
63. Rössle M, Haag K, Ochs A, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171.
64. Burroughs AK, Vangeli M: Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: Randomized trials for secondary prophylaxis of variceal bleeding: An updated meta-analysis. Scand J Gastroenterol 2002;37: 249-252.
65. Escorsell A, Banares R, Garcia-Pagan JC, et al: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35: 385-392.
66. Norton ID, Andrews JC, Kamath PS: Management of ectopic varices. Hepatology 1998;28: 1154-1158.
67. Ninoi T, Nakamura K, Kaminou T, et al: TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol 2004;183:369-376.
68. Rees CJ, Nylander DL, Thompson NP, Rose JD, Record CO, Hudson M: Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver 2000;20:253-256.
69. Wu CY, Yeh HZ, Chen GH: Pharmacologic efficacy in gastric variceal rebleeding and survival: Including multivariate analysis. J Clin Gastroenterol 2002;35:127-132.
70. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA: Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000;118:905-911.
71. Obideen MK, Wehbi M, Ghazale A, Martinez E, Cai Q: Efficacy and safety of transjugular intrahepatic portosystemic shunt in the treatment of nongastric extraesophageal variceal bleeding. J Clin Gastroenterol 2004;38:373-376.
72. Illuminati G, Smail A, Azoulay D, Castaing D, Bismuth H: Association of transjugular intrahepatic portosystemic shunt with embohzation in the treatment of bleeding duodenal varix refractory to sclerotherapy. Dig Surg 2000; 17:398-400.
73. Runyon BA: Care of patients with ascites. N Engl J Med 1994;330:337-342.
74. Gines P, Cardenas A, Arroyo V, Rodes J: Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-1654.
75. Moore KP, Wong F, Gines P, et al: The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-266.
76. Arroyo V, Gines P, Gerbes AL, et al: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis (review). International Ascites Club. Hepatology 1996;23: 164-176.
77. Runyon BA: Historical aspects of treatment of patients with cirrhosis and ascites. Semin Liver Dis 1997;17:163-173.
78. Ochs A, Siegerstetter V: TIPS and refractory ascites, hepatorenal syndrome and other complications; in Hulek P, Krajina A (eds): Current Practice of TIPS. Hradec Kralove, Olga Stambergova 2001, pp 133-142.
79. Peron JM, Barange K, Otal P, et al: Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: Results in 48 consecutive patients. J Vasc Intervent Radiol 2000;11:1211-1216.
80. Nair S, Singh R, Yoselewitz M : Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites. J Vasc Intervent Radiol 2004;15:1431-1434.
81. Wong W, Liu P, Blendis LM, Wong F: Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Am J Med 1999;106:315-322.
82. Jalan R, Redhead DN, Thomas HW, et al: Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996;8:1111-1116.
83. Plauth M, Schutz T, Buckendahl DP, et al: Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J Hepatol 2004;40:228-233.
84. Sandokji AM, Chau J, Aghdassi E, Wong F, Blendis LM, Allard JP: Effects of transjugular intrahepatic portosystemic shunt (TIPS) on nutritional status and comparison between methods of measuring fat free mass (FFM) in patients with liver cirrhosis. Gastroenterology 1997;112:A903.
85. Scheib SA, Caldwell SH, Driscoll CJ, et al: Improvment in nutritional parameters and Child-Pugh class after TIPS for refractory ascites. Hepatology 1996;24:574A.
86. Allard JP, Chau J, Sandokji K, Blendis LM, Wong F: Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001;96:2442-2447.
87. Lebrec D, Giuily N, Hadengue A, et al: Transjugular intrahepatic portosystemic shunts - comparison with paracentesis in patients with cirrhosis and refractory ascites - a randomized trial. J Hepatol 1996;25:135-144.
88. Rössle M, Ochs A, Gülberg V, et al: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-1707.
89. Gines P, Uriz J, Calahorra B, et al: Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-1847.
90. Sanyal AJ, Genning C, Reddy KR, et al: The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124:634-641.
91. Salerno F, Merli M, Riggjo O, et al: Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004;40:629-635.
92. Rosemurgy AS, Zervos EE, Clark WC, et al: TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: A prospective randomized trial. Ann Surg 2004; 239:883-889.
93. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M: Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529-534.
94. Gordon FD, Anastopoulos HT, Crenshaw W, et al: The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366-1369.
95. Nolte W, Figulla HR, Ringe B, et al: Refractory hydrothorax in primary biliary cirrhosis - successful treatment with a transjugular intrahepatic portosytemic stent shunt. Dtsch Med Wochenschr 1997;122:1275-1280.
96. Petruff CA, Anastopoulos HT, Chopra S, McEniff N, Lewis WD: The successful use of TIPS for the treatment of symptomatic refractory hepatic hydrothorax: long-term follow up. Hepatology 1996;24:190A.
97. Andrade RJ, Martin-Palanca A, Fraile JM, et al: Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996;22:305-307.
98. Strauss RM, Martin LG, Kaufman SL, Boyer TD: Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994;89:1520-1522.
99. Haskal ZJ, Zuckerman J: Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994;106:1293-1295.
100. Angeli P: Review article: prognosis of hepatorenal syndrome - has it changed with current practice? Aliment Pharmacol Ther 2004; 20(suppl 3):44-46.
101. Wong F, Pantea L, Sniderman K: Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55-64.
102. Gines P, Guevara M, Perez-Villa F: Management of hepatorenal syndrome: another piece of the puzzle. Hepatology 2004;40:16-18.
103. Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T: Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome [letter]. Lancet 1997;349: 697-698.
104. Cardenas A: The Budd-Chiari syndrome. N Engl J Med 2004;350:1906-1908.
105. Ochs A, Sellinger M, Haag K, et al: Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993;18:217-225.
106. Peltzer MY, Ring EJ, LaBerge JM, Haskal ZJ, Radosevich PM, Gordon RL: Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1993;4:263-267.
107. Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D: The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
108. Blokzijl H, de Knegt RJ: Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt. Hepatology 2002;35:1551-1552.
109. Gasparini D, Del FM, Sponza M, et al: Transjugular intrahepatic portosystemic shunt by direct transcaval approach in patients with acute and hyperacute Budd-Chiari syndrome. Eur J Gastroenterol Hepatol 2002; 14:567-571.
110. Perello A, Garcia-Pagan JC, Gilabert R, et al: TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35:132-139.
111. Blum U, Rössle M, Haag K, et al: Budd-Chiari Syndrome - technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995;197:805-811.
112. Hernandez-Guerra M, Turnes J, Rubinstein P, et al: PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40:1197-1202.
113. Fried MW, Connaghan DG, Sharma S, et al: Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996;24:588-591.
114. Zenz T, Rössle M, Bertz H, Siegerstetter V, Ochs A, Finke J: Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation - role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001;21:31-36.
115. Blum U, Haag K, Rössle M, et al: Noncavernomatous portal vein thrombosis in hepatic cirrhosis - treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 1995;195:153-157.
116. Bilbao JI, Elorz M, Vivas I, Martinez-Cuesta A, Bastarrika G, Benito A: Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 2004;27:474-480.
117. Cherukuri R, Haskal ZJ, Naji A, Shaked A: Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up. Transplantation 1998;65:1124-1126.
118. Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB: Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol 1998;93:455-458.
119. Allgaier HP, Haag K, Ochs A, et al: Hepatopulmonary syndrome - successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS). J Hepatol 1995;23:102.
120. Krowka MJ: Hepatopulmonary syndrome: what are we learning from interventional radiology, liver transplantation, and other disorders? Gastroenterology 1995;109:1009-1013.
121. Burger JA, Ochs A, Wirth K, et al: The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients. Ann Oncol 1997;8: 200-202.
122. Gimson AE: Transjugular intrahepatic portosystemic stent-shunt and liver transplantation - how safe is the bridge? Eur J Gastroenterol Hepatol 2002;14:821-822.
123. Tripathi D, Therapondos G, Redhead DN, Madhavan KK, Hayes PC: Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2002;14:827-832.
124. Maleux G, Pirenne J, Vaninbroukx J, Aerts R, Nevens F: Are TIPS stent-grafts a contraindication for future liver transplantation? Cardiovasc Intervent Radiol 2004;27:140-142.